Legal & General Group’s Tourmaline Bio TRML Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $128K | Sell |
8,017
-7,426
| -48% | -$119K | ﹤0.01% | 2625 |
|
2025
Q1 | $235K | Hold |
15,443
| – | – | ﹤0.01% | 2585 |
|
2024
Q4 | $313K | Buy |
15,443
+10,250
| +197% | +$208K | ﹤0.01% | 2599 |
|
2024
Q3 | $134K | Sell |
5,193
-14,031
| -73% | -$361K | ﹤0.01% | 2711 |
|
2024
Q2 | $247K | Buy |
19,224
+4,211
| +28% | +$54.2K | ﹤0.01% | 2638 |
|
2024
Q1 | $344K | Buy |
+15,013
| New | +$344K | ﹤0.01% | 2567 |
|
2023
Q2 | – | Sell |
-1,991
| Closed | -$3.74K | – | 3514 |
|
2023
Q1 | $3.74K | Hold |
1,991
| – | – | ﹤0.01% | 3326 |
|
2022
Q4 | $2.03K | Hold |
1,991
| – | – | ﹤0.01% | 3393 |
|
2022
Q3 | $5K | Hold |
1,991
| – | – | ﹤0.01% | 3410 |
|
2022
Q2 | $9K | Sell |
1,991
-117
| -6% | -$529 | ﹤0.01% | 3385 |
|
2022
Q1 | $21K | Buy |
2,108
+99
| +5% | +$986 | ﹤0.01% | 3233 |
|
2021
Q4 | $31K | Buy |
2,009
+1,151
| +134% | +$17.8K | ﹤0.01% | 3143 |
|
2021
Q3 | $12K | Hold |
858
| – | – | ﹤0.01% | 3420 |
|
2021
Q2 | $13K | Buy |
+858
| New | +$13K | ﹤0.01% | 3402 |
|